ProUroCare Medical Inc.
OTC: PUMD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Technology
- Industry
- Consumer Electronics
- CEO
- Benjamin Banks
- Employees
- 2
- Headquarters
- Eden Prairie, United States
- IPO year
- 2022
- Market cap
- $1.9K
- Website
- https://www.prourocare.com
Loading PUMD…
Loading profile data…Frequently asked questions about PUMD
What does ProUroCare Medical Inc. (PUMD) do?
ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been init...
Where does PUMD trade?
ProUroCare Medical Inc. (PUMD) trades on the Other OTC.
What sector is PUMD in?
ProUroCare Medical Inc. (PUMD) operates in the Technology sector, specifically in the Consumer Electronics industry.
Who is the CEO of ProUroCare Medical Inc.?
Benjamin Banks is the chief executive officer of ProUroCare Medical Inc. (PUMD).
Where is ProUroCare Medical Inc. headquartered?
ProUroCare Medical Inc. is headquartered in United States.
Does PUMD pay a dividend?
ProUroCare Medical Inc. (PUMD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PUMD go public?
ProUroCare Medical Inc. (PUMD) completed its initial public offering in 2022.